STAAR Surgical (STAA) Misses Q1 EPS by 52c, withdraws guidance

STAAR Surgical (NASDAQ: STAA) reported Q1 EPS of ($1.10), $0.52 worse than the analyst estimate of ($0.58). Revenue for the quarter came in at $42.6 million versus the consensus estimate of $40.33 million.

Outlook

The Company announced that it is withdrawing the financial outlook previously provided on February 11, 2025.

“Global economic uncertainty and evolving tariff policy make it more challenging to forecast. As a result, despite confidence in our recent efforts to mitigate tariff exposure and our optimism regarding both short-term and long-term business trends, we are withdrawing the Company’s previous financial outlook,” concluded Mr. Farrell.

For earnings history and earnings-related data on STAAR Surgical (STAA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Tradr 2X Long SpaceX Daily ETF (SPCM) call put ratio 6.8 calls to 1 put with a focus on July 28 calls as share price down 20.6%
• Trump administration proposes looser oil drilling rules